Leonie Jochheim

机构：Essen University Hospital, University of Duisburg-Essen · ORCID：0009-0003-4522-9343

发表论文 46 篇 · 总被引 305 次 · h-index 10

代表论文

• Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events (2024 · JHEP Reports · 被引 18)
• The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update (2025 · Seminars in Nuclear Medicine · 被引 15)
• Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort (2024 · Hepatology Communications · 被引 14)
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab (2024 · JHEP Reports · 被引 10)
• Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) (2025 · BMJ Open · 被引 9)
• Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 5)